Synexus Clinical Research GmbH

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease2 trials
• Amyloidosis1 trial
• Migraine1 trial
• Obesity1 trial

Phase

• Phase 22 trials
• Phase 32 trials
• Phase 41 trial

Status

• Completed4 trials
• Active, not recruiting1 trial

Lead sponsor

• Boehringer Ingelheim3 trials
• Alnylam Pharmaceuticals Inc.1 trial
• Pfizer1 trial

Running trials

• Active, not recruiting

  A Study to Evaluate Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy

  2024-518318-25-00· Phase 3· Alnylam Pharmaceuticals Inc.· Source

Closed trials

• Completed

  A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease

  NCT06926660· Phase 2· Boehringer Ingelheim· Source

• Completed

  A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

  NCT06077864· Phase 3· Boehringer Ingelheim· Source

• Completed

  Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications

  NCT05518123· Phase 4· Pfizer· Source

• Completed

  A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)

  NCT04771273· Phase 2· Boehringer Ingelheim· Source